Si può desiderare di provare un trattamento naturale disfunzione erettile come un diverso per i problemi di costruzione. Al giorno d oggi ci sono diverse terapie sul mercato, ma un trattamento naturale disfunzione erettile è stato confermato qualche ora e ora di nuovo per dare risultati efficienti e permanenti. Cos è la disfunzione sessuale? L incapacità di sviluppare o sostenere una costruzione abbastanza lungo per fare l amore è chiamato disfunzione erettile, ED https://farmacia-senzaricetta.it/ o (maschio) problemi di erezione. Tutti gli uomini possono avere problemi di costruzione di volta in volta e gli scienziati considerano ED essere presenti se si verificano problemi di costruzione almeno il 25% del tempo. Alcuni fatti duri: ED Può essere dovuto a problemi emotivi. Stress, pressione, giltiness, depressione, bassa autostima e ansia prestazioni può essere la causa dei vostri problemi di costruzione. La ricerca ha confermato che il 90 per cento della disfunzione erettile è fisica in origine, non emotiva. L impotenza colpisce la maggior parte degli uomini durante la loro vita e può essere dovuto a troppo colesterolo, problemi cardiaci, diabete, ipertensione, fumo o alcol. Alcuni rimedi possono essere la ragione. Le questioni legate al movimento sono collegate. Se ti occupi dei tuoi problemi di movimento, hai piu possibilita di risolvere questo problema. Qui ci sono 5 consigli facili su come aumentare la circolazione: 1. Mangia i pasti giusti. Questo ti rendera il flusso sanguigno ovvio. Una grande parte di rimanere sani e anche mantenere il flusso sanguigno ovvio è legato al vostro piano di alimentazione quotidiana e quello che si mangia. Una buona cura per la disfunzione erettile è mangiare un piano a basso contenuto di grassi e grande alimentazione di fibre. Mangiare fibre tutti i giorni e questo viene scoperto in prodotti cerealicoli cereali integrali, frutta e verdura. Evitare il più possibile pasti pronti o pasti non sani. 2. Wonder herbal rimedi. Molti rimedi vegetali per ED eseguire bene come possono migliorare il movimento. Hanno molto meno reazioni avverse rispetto ai farmaci convenzionali e si svolgono in modo efficiente per migliorare hardons e la forza, troppo. Erbe naturali come Ginkgo Biloba sono utilizzati come una strategia per ED. Gli specialisti di erboristeria credono anche che le spezie o le erbe come noce moscata, portano al movimento intorno al corpo, tra cui il pene. 3. Vitamine naturali vitali. Gli scienziati sanitari hanno scoperto che una mancanza di supplemento è tipico tra gli uomini con ED in particolare vitamina A. Se si ha una mancanza del nutriente ossido di zinco, Questo è stato confermato per portare alla disfunzione erettile. Queste inadeguatezze derivano dal fatto che molti valori nutrizionali in quello che mangiamo piano non sono sufficienti. Aggiungere al vostro fabbisogno di nutrienti aumenterà la circolazione del sistema e migliorare questa condizione. Gli integratori alimentari sono completamente naturali, quindi non dovrete preoccuparvi dei rischi di reazioni avverse. Inoltre, queste vitamine naturali sono utili per il vostro benessere over-all. Oltre a questi vantaggi benessere, disfunzione erettile vitamine naturali e integratori costano molto meno di farmaci rimedi. 4. Esercitare. Fai una mossa e non un tablet vibrante. Camminare farà di più per migliorare e sostenere hardons di qualsiasi altra compressa chimica nel lungo periodo. Il fitness fisico manterrà bassi livelli di pressione e mantenere grandi stadi di movimento. Andando per un 20-30 minuti di movimento rapido ogni giorno, può affrontare questo problema e può sostenere la vostra libido senza l uso di qualsiasi farmaco. 5. Sottolineare. Questo è il peggior attaccante per problemi di erezione. Scopri diversi metodi per riposare. Alcuni metodi tipici per riposare includono la lettura di un libro, la meditazione, un bagno rilassante o allenamenti di respirazione. Sto solo imparando alcuni semplici allenamenti di respirazione che possono migliorare significativamente il movimento nel reparto pantaloni. Una naturale disfunzione erettile soluzioni di trattamento stanno diventando sempre più popolare con gli uomini. Questi rimedi a base di erbe sono preferiti perché non hanno reazioni avverse e sono confermati essere efficiente come il farmaco. La maggior parte degli uomini combattere parlano dei loro problemi, in particolare la disfunzione erettile come c è poca discussione sui problemi di erezione. La verita e che ED ha un impatto su piu di dieci milioni di uomini solo negli Stati Uniti. Non siete soli e l aiuto è disponibile.

Derma.med.uni-erlangen.de

Multifocal disseminated lipoatrophy secondary
to intravenous corticosteroid administration in a patient
with adrenal insufficiency
Jürgen Bauerschmitz, MD, and Konrad Bork, MD Mainz, Germany Multifocal disseminated lesions of circumscribed lipoatrophy have not been described as an adverse reaction of intravenously applieddrugs. A unique patient with adrenal insufficiency is reported who received corticosteroids intravenously and then had multiplelesions develop that were similar to focal lipoatrophy as known to occur secondary to faulty intradermal injections of corticosteroids.
(J Am Acad Dermatol 2002;46:S130-2.) Long-lasting localized lipoatrophy is well known as a local hormones revealed a normal anterior pituitary reaction (soma- adverse reaction secondary to injections of corticosteroid totropic hormone, luteinizing hormone, follicle-stimulating hor- crystal suspension into subcutaneous tissue and after sub- mone, thyroid-stimulating hormone, prolactin). Thus, the diag- cutaneous injections of insulin. It may also occur as an untoward nosis of a hypothalamic hypoadrenalism was established.
result of inappropriate intramuscular injections. Postinjection Substitution therapy was initiated with intravenous infusions lipoatrophy at the injection site is also reported to occur after of 300 mg prednisolone-21-hydrogen succinate (Solu-Decortin administration of benzathine penicillin, vasopressin and human H, Merck, Darmstadt, Germany) per day. Five days later, 5 focal growth hormone.1 Insulin lipoatrophy consists of loss of fat at cutaneous lesions started developing without a preceding inflam- injection sites and occasionally at sites distant from the site of matory and symptomatic phase. There was no erythema either at insulin injection.1-6 Multifocal disseminated lesions of circum- the beginning or in later stages. Two weeks later, the lesions were scribed lipoatrophy, however, have not been described as an fully developed. The lipoatrophy lesions were well-demarcated, adverse reaction of intravenously applied drugs. We describe a round or oval depressions without epidermal alteration or dis- unique patient with adrenal insufficiency who received corticos- coloration ranging from 3 to 10 cm in diameter (Fig 1). The teroids and then had multiple lesions develop that were similar affected areas were the upper back, the upper chest region, the to focal lipoatrophy as known to occur secondary to faulty intra- right upper arm, and the inner aspect of the thigh. Histo- dermal injections of corticosteroids.
pathologic examination revealed a marked focal decrease of thesubcutaneous fat tissue with numerous small lipocytes and with CASE REPORT
broadening of the fat septa without any inflammatory reaction.
A 58-year-old woman with a 10-year history of nesidioblastoma The epidermis and the dermis were normal. There was no fibro- and partial pancreatectomy had a hypothalamic insufficiency of sis in the dermis. Neither clinically nor histologically were there unknown origin for 1 year. Symptoms consisted of adynamy, signs of morphea and anetodermas. The patient did not receive weakness, weight loss, and loss of appetite. Several episodes of intradermal, subcutaneous, or intramuscular injections before or serious hypoglycemia had occurred. There was no evidence of after the skin lesions developed. The history of trauma, ie, place- insulinoma, relapse of nesidioblastoma, or Addison’s disease of ment of electrocardiogram leads, intravenous tourniquets, was anterior pituitary failor. Laboratory values of insulin and c-peptide were below the normal limits, the values of proinsulin, insulin- After switching the administration route to an oral intake of like growth factors, and vasoactive intestinal peptide were within the medication and after tapering the dose to 12.5 mg pred- the limits of normal. Plasma cortisol levels, however, were nisolone per day, which was maintained for 2 years, the lesions extremely low (1 µg/100 mL; normal value: 5 to 25 µg/100 mL).
There was no increase in plasma cortisol after stimulation withcorticotropin-releasing factor and adrenocorticotrophic hor- DISCUSSION
mone or by hypoglycemia. Stimulation tests with hypothalamic Atrophy of the subcutaneous fatty tissue is recognized as a result of several types of inflammatory panniculitis,7-13 or itoccurs as a localized loss of adipose tissue without prior inflam- This supplement is made possible through an unrestricted mation and is then termed idiopathic lipoatrophy. Other clinical grant from Stiefel Laboratories to the American Academy of patterns of localized involutional lipoatrophy are semicircular and annular lipoatrophies.14,15 Idiopathic lipoatrophy may devel- From the Department of Dermatology, University of Mainz.
op after injections of drugs, predominantly corticosteroids and Reprint requests: Prof Dr Konrad Bork, Department of Dermatology, insulin. A clinicopathologic retrospective study was reported in University of Mainz, Langenbeckstr.1, D-55101 Mainz, Germany. E-mail:[email protected].
which 16 patients with localized idiopathic lipoatrophy were Copyright 2002 by the American Academy of Dermatology, Inc.
included.16 Eight of the patients had received intramuscular or 16/4/107490
intra-articular injection of corticosteroids at the affected site before the development of the lipoatrophy; 1 patient received Bauerschmitz and Bork S131
Fig 1. Multifocal lipoatrophic lesions. A, Upper chest region. B, Upper back.
the injection in combination with antibiotics and another patient dose corticosteroid infusions and the development of the multi- received it along with methotrexate. Two patients had received focal disseminated lipoatrophy make it likely that the lipoatroph- intramuscular injections of antibiotics alone. No injections were ic lesions are caused by the intravenously injected corticos- recalled in 4 patients, and the injection status was unknown in 2 teroids. This type of reaction, however, has yet not been patients. The buttocks and arms were involved most frequently.
described as a side effect of intravenously or perorally adminis- The histopathologic findings consisted of lobules of small tered corticosteroids. It can be assumed that the low plasma level lipocytes. Inflammatory cells were not prominent, although a and therefore also the low tissue concentration of cortisol for a scant mononuclear cell infiltrate was observed. Vascular inflam- long period has made the patient susceptible to this type of reac- mation was absent. These changes are typical for the noninflam- tion. The rapid marked increase of the tissue levels of corticos- matory type of lipoatrophy and had been termed involutional teroids and thus also in the subcutaneous fat tissue might be lipoatrophy.17 Electron microscopic studies revealed a close rela- responsible for the multifocal lipoatrophy. Pathogenesis might be tionship between the macrophages and the involutional fat comparable with the well-known lipoatrophy at the injection site cells.18 It is unclear whether the macrophages are the cause or secondary to corticosteroid injections, predominantly triamci- nolone, the so-called cortisone atrophy. If in subfocal injections All patients reported by Dahl et al16 were female. A remarkable corticosteroid crystal suspension is not injected in the dermal female predominance in lipoatrophy after corticosteroid injec- connective tissue but too deeply, or if the intramuscular injection tions has also been reported by Fisherman et al.19 Lipoatrophy is too superficial, the corticosteroid crystals accumulate in the occurred in 6 of 14 women but in none of the 13 men receiving subcutaneous fatty tissue and induce a focal lipoatrophy. The repeated injections of triamcinolone diacetate.19 Although none of focal lipoatrophy is obviously caused by a locally increased corti- the patients reported by Dahl et al16 and Fisherman et al19 or our costeroid concentration in the fatty tissue. In the patient patient had diabetes mellitus, prior studies have recognized that described in our report, the initially low cortisol levels in the fatty female patients have a predisposition to insulin injection–associ- tissue because of the adrenal insufficiency in combination with ated lipoatrophy.16,19 Specifically localized atrophic insulin lipody- the sudden high corticosteroid levels after the intravenous strophy occurs most commonly in children and young women.2,3,5 administration of prednisolone probably gave rise to a sudden Before availability of purified insulin, injection site lipoatrophy was enormous increase of corticosteroid level in the fatty tissue of the the most common localized complication of treatment with entire skin. This increase might be the reason that the lipoat- insulin, with an overall patient prevalence of 24%, children had a rophic lesions occur and that they are multifocal and disseminat- prevalence of about 50%. In about a quarter of patients, insulin ed. It does not explain why the lesions are circumscribed. The lipoatrophy occurs simultaneously with insulin lipohypertrophy.6 effect, however, might be comparable to that of corticosteroid A high frequency (25%) of local allergy of the immediate type sug- accumulation in the fatty tissue after subcutaneous injections gests an immunologic mechanism for lipoatrophy in response to inducing localized cortisone atrophy.
injected insulin. Histopathologic findings of biopsied nonatroph-ic, inflamed injection sites are reminiscent of an urticarial allergic REFERENCES
reaction as well as a localized low-grade immune complex associ- 1. Bork K. Cutaneous side effects of drugs. 2nd ed. Stuttgart: Schattauer; ated allergic vasculitis.6 Atlan-Gepner et al2 reported a local hyper- production of tumor necrosis factor alpha and interleukin 6 from 2. Atlan-Gepner C, Bongrand P, Farnarier C, Xerri L, Choux R, Gauthier JF, et al. Insulin-induced lipoatrophy in type I diabetes: a possible tumor macrophages that was induced by injected insulin and that could necrosis factor-alpha-mediated dedifferentiation of adipocytes.
mediate the dedifferentiation of adipocytes of the subcutaneous tissue in the insulin-induced lipoatrophy of a patient with type 1 3. Bloom A. Fat atrophy due to insulin. Br Med J 1972;4:366.
4. Friedman RH. Lipoatrophy after benzathine penicillin. J Pediatr Our patient had disseminated focal areas of lipoatrophy. The data do not support the existence of an early inflammatory phase 5. Jaap AJ, Horn HM, Tidman MJ, Walker JD. Lipoatrophy with human neither clinically nor histologically. The lipoatrophic lesions were insulin. Diabetes Care 1996;19:1289-90.
not sequelae of prior intradermal, subcutaneous, or intramuscu- 6. Morgan AM. Localized reactions to injected therapeutic materials: part lar injections. The close temporal relationship between the large- 1. Medical agents. J Cutan Pathol 1995;22:193-214.
S132 Bauerschmitz and Bork
7. Ahn S, Yoo M, Lee S, Choi E. A clinical and histopathological study of 22 14. Jablonska S, Szczepanski A, Gorkiewicz A. Lipo-atrophy of the ankles patients with membranous lipodystrophy. Clin Exp Dermatol 1996;21: and its relation to other lipo-atrophies. Acta Derm Venereol 1975;55: 8. Chun SL, Ahn SK, Kim SC. Membranous lipodystrophy: primary idio- 15. Rongioletti F, Rebora A. Annular and semicircular lipoatrophies. J Am pathic type. J Am Acad Dermatol 1991;24:844-7.
9. Chun SL, Chung KY. Membranous lipodystrophy: secondary type. J Am 16. Dahl PR, Zalla MJ, Winkelmann RK. Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol 1996;35: 10. Kim KT, Ahn SK, Choi EH, Lee SH. Membranous lipodystrophy associat- ed with insulin lipoatrophy. Int J Dermatol 1997;36:299-301.
17. Peters MS, Winkelmann RK. The histopathology of localized lipoatro- 11. Peters MS, Winkelmann RK. Localized lipoatrophy (atrophic connective tissue disease panniculitis). Arch Dermatol 1980;116:1363-8.
18. Zalla MJ, Winkelmann RK, Gluck OS. Involutional lipoatrophy: 12. Umbert IJ, Winkelmann RK. Adult lipophagic atrophic panniculitis. Br J macrophage-related involution of fat lobules. Dermatology 1995;191: 13. Winkelmann RK, McEvoy MT, Peters MS. Lipophagic panniculitis of 19. Fisherman EW, Feinberg AR, Feinberg SM. Local subcutaneous atrophy.
childhood. J Am Acad Dermatol 1989;21:971-81.

Source: http://www.derma.med.uni-erlangen.de/e1585/e1893/e3827/e3831/inhalt3164/BauerschmitzJ_Multifocal_disseminated_JAAD2003part2Vol46No5_p130_ger.pdf